Heidi Levens

Director, Patient Safety at Bristol-Myers Squibb

Heidi Levens is an accomplished professional in the field of pharmacovigilance with extensive experience spanning over three decades. Currently serving as Director of Patient Safety at Bristol Myers Squibb since March 2009, Heidi has held various leadership roles including Head of Canada for Patient Safety and Head of Country for Pharmacovigilance in Canada and FSA. Prior to this, experience at Novartis includes positions such as Pharmacovigilance Coordinator and Laboratory Research Associate. Academic qualifications include an M.Sc. in Pharmacovigilance with Distinction from the University of Hertfordshire and a B.Sc. (Hons) in Life Sciences from The Open University, along with a diploma in Organic Chemistry from Basler Gewerbe Schule.

Links

Previous companies

Novartis logo

Org chart

Timeline

  • Director, Patient Safety

    January, 2022 - present

  • Head Of Canada, Patient Safety

    July, 2020

  • Head Of Country For Pharmacovigilance, Canada And FSA

    December, 2016

  • Documentation Manager, Global Safety Risk Management

    January, 2016

  • Senior Pharmacovigilance Associate

    March, 2015

  • Pharmacovigilance Associate II

    March, 2009